Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-12-10 4:31 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 2,408,395 5.2% | 2,408,395 (New Position) | View |
| 2021-04-05 5:28 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | BRISTOL MYERS SQUIBB CO BMY | 1,726,197 3.8% | 1,726,197 (New Position) | View |
| 2021-02-16 4:30 pm Sale | 13G | SUTRO BIOPHARMA INC STRO | CITADEL ADVISORS LLC | 1,301,804 2.9% | -427,172 (-24.71%) | View |
| 2021-02-16 4:22 pm Sale | 13G | SUTRO BIOPHARMA INC STRO | Ridgeback Capital Investments L.P. | 1,144,979 2.5% | -869,708 (-43.17%) | View |
| 2021-02-16 08:57 am Sale | 13G | SUTRO BIOPHARMA INC STRO | Alta Partners VIII L.P. | 0 0% | -1,948,516 (Position Closed) | View |
| 2021-02-12 5:23 pm Sale | 13G | SUTRO BIOPHARMA INC STRO | EcoR1 Capital LLC | 93,416 0.2% | -2,235,076 (-95.99%) | View |
| 2021-02-12 4:25 pm Sale | 13G | SUTRO BIOPHARMA INC STRO | BIOTECHNOLOGY VALUE FUND L P | 1,854,162 4.1% | -514,230 (-21.71%) | View |
| 2021-02-12 4:10 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | EVENTIDE ASSET MANAGEMENT LLC | 2,370,975 5.3% | 1,126,080 (+90.46%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | BlackRock Inc. BLK | 2,717,929 6.2% | 2,717,929 (New Position) | View |
| 2020-08-28 4:06 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | EcoR1 Capital LLC | 2,328,492 6.5% | 2,328,492 (New Position) | View |
| 2020-08-24 6:54 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | Ridgeback Capital Investments L.P. | 2,014,687 5.3% | 2,014,687 (New Position) | View |
| 2020-05-22 5:22 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | BIOTECHNOLOGY VALUE FUND L P | 2,368,392 6.6% | 2,368,392 (New Position) | View |
| 2020-02-14 4:07 pm Sale | 13G | SUTRO BIOPHARMA INC STRO | CITADEL ADVISORS LLC | 1,728,976 7.5% | -67 (-0.00%) | View |
| 2020-02-13 4:17 pm Sale | 13G | SUTRO BIOPHARMA INC STRO | Lilly Ventures Fund I LLC | 968,161 4.2% | -572,652 (-37.17%) | View |
| 2020-02-12 2:28 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | Skyline Venture Partners V LP | 1,960,053 8.5% | 1,960,053 (New Position) | View |
| 2020-02-10 5:26 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | CELGENE CORP CELG | 1,726,197 7.5% | 1,726,197 (New Position) | View |